Chargement en cours...
Urinary 11‐Dehydro‐Thromboxane B(2) as a Predictor of Acute Myocardial Infarction Outcomes: Results of Leukotrienes and Thromboxane In Myocardial Infarction (LTIMI) Study
BACKGROUND: Urinary 11‐dehydro‐thromboxane (TX)B(2) has been described as a potential predictive biomarker of major adverse cardiovascular events (MACEs) in high cardiac risk patients. This part of LTIMI (Leukotrienes and Thromboxane In Myocardial Infarction) study aimed to evaluate the relationship...
Enregistré dans:
| Publié dans: | J Am Heart Assoc |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5015290/ https://ncbi.nlm.nih.gov/pubmed/27481134 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.116.003702 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|